{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:23:09Z","timestamp":1794244989995,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T00:00:00Z","timestamp":1424217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12954-015-0037-2","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T08:40:26Z","timestamp":1424162426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden"],"prefix":"10.1186","volume":"12","author":[{"given":"Torkel","family":"Richert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2011;10.","DOI":"10.1002\/14651858.CD004147.pub4"},{"key":"37_CR2","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;2.","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"37_CR3","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3.","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"45","key":"37_CR4","first-page":"2309","volume":"108","author":"B Johnson","year":"2011","unstructured":"Johnson B. Methadone and buprenorphine: attractive on the street and outside treatment programs. Lakartidningen. 2011;108(45):2309\u201311.","journal-title":"Lakartidningen"},{"issue":"1","key":"37_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","volume":"4","author":"MA Yokell","year":"2011","unstructured":"Yokell MA, Zaller ND, Green TC, Rich JD. Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev. 2011;4(1):28\u201341.","journal-title":"Curr Drug Abuse Rev"},{"issue":"7","key":"37_CR6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1360-0443.2003.00425.x","volume":"98","author":"A Seymour","year":"2003","unstructured":"Seymour A, Black M, Jay J, Cooper G, Weir C, Oliver J. The role of methadone in drug-related deaths in the west of Scotland. Addiction. 2003;98(7):995\u20131002.","journal-title":"Addiction"},{"issue":"6","key":"37_CR7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ije\/dyl207","volume":"35","author":"O Morgan","year":"2006","unstructured":"Morgan O, Griffiths C, Hickman M. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993\u20132004. Int J Epidemiol. 2006;35(6):1579\u201385.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"37_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1360-0443.2006.01714.x","volume":"102","author":"A Fugelstad","year":"2007","unstructured":"Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007;102(3):406\u201312.","journal-title":"Addiction"},{"key":"37_CR9","doi-asserted-by":"crossref","first-page":"c4851","DOI":"10.1136\/bmj.c4851","volume":"341","author":"J Strang","year":"1993","unstructured":"Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose. BMJ. 1993;341:c4851.","journal-title":"BMJ"},{"issue":"2","key":"37_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAF.0b013e3181e8af3d","volume":"32","author":"ME Madden","year":"2011","unstructured":"Madden ME, Shapiro SL. The methadone epidemic: methadone-related deaths on the rise in Vermont. Am J Forensic Med Pathol. 2011;32(2):131\u20135.","journal-title":"Am J Forensic Med Pathol"},{"issue":"6","key":"37_CR11","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","volume":"24","author":"M Harris","year":"2012","unstructured":"Harris M, Rhodes T. Methadone diversion as protective strategy: the harm reduction potential of \u2018generous constraints\u2019. Int J Drug Policy. 2012;24(6):e43\u201350.","journal-title":"Int J Drug Policy"},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0376-8716(03)00061-9","volume":"2","author":"TP Bridge","year":"2003","unstructured":"Bridge TP, Fudala PJ, Herbert S, Leiderman DB. Safety and health policy considerations related to the use of buprenorphine\/naloxone as an office-based treatment for opiate dependence. Drug Alcohol Depend. 2003;2:S79\u201385.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"37_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000104883","volume":"13","author":"A H\u00e5kansson","year":"2007","unstructured":"H\u00e5kansson A, Medvedeo A, Andersson M, Berglund M. Buprenorphine misuse among heroin and amphetamine users in Malm\u00f6, Sweden: purpose of misuse and route of administration. Eur Addict Res. 2007;13(4):207\u201315.","journal-title":"Eur Addict Res"},{"issue":"3","key":"37_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","volume":"28","author":"A Monte","year":"2009","unstructured":"Monte A, Mandell T, Wilford B, Tennyson J, Boyer E. Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence. J Addict Dis. 2009;28(3):226\u201331.","journal-title":"J Addict Dis"},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7517-10-27","volume":"10","author":"T Richert","year":"2013","unstructured":"Richert T, Johnson B. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden. Harm Reduct J. 2013;10:27.","journal-title":"Harm Reduct J"},{"issue":"5","key":"37_CR16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","volume":"18","author":"SG Mitchell","year":"2009","unstructured":"Mitchell SG, Kelly SM, Brown BS, Schacht Reisinger H, Peterson JA, Ruhf A, et al. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am J Addict. 2009;18(5):346\u201355.","journal-title":"Am J Addict"},{"issue":"1","key":"37_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","volume":"39","author":"Z Schuman-Olivier","year":"2010","unstructured":"Schuman-Olivier Z, Albanese M, Nelson SE, Roland L, Puopolo F, Klinker L, et al. Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat. 2010;39(1):41\u201350.","journal-title":"J Subst Abuse Treat"},{"key":"37_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drugalcdep.2012.05.025","volume":"126","author":"MR Lofwall","year":"2012","unstructured":"Lofwall MR, Havens JR. Inability to access buprenorphine treatment as risk factor for using diverted buprenorphine. Drug Alcohol Depend. 2012;126:379\u201383.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"37_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson","year":"2010","unstructured":"Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O\u2019Grady KE, et al. Why don\u2019t out-of-treatment individuals enter methadone treatment programs? Int J Drug Policy. 2010;21(1):36\u201342.","journal-title":"Int J Drug Policy"},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000320576","volume":"17","author":"H St\u00f6ver","year":"2011","unstructured":"St\u00f6ver H. Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians. Eur Addict Res. 2011;17:44\u201354.","journal-title":"Eur Addict Res"},{"issue":"6","key":"37_CR21","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.drugpo.2013.04.006","volume":"24","author":"CS Schmidt","year":"2013","unstructured":"Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, et al. Non-prescribed use of substitution medication among German drug users: prevalence, motives and availability. Int J Drug Policy. 2013;24(6):e111\u20134.","journal-title":"Int J Drug Policy"},{"issue":"9358","key":"37_CR22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","volume":"361","author":"J Kakko","year":"2003","unstructured":"Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet. 2003;361(9358):662\u20138.","journal-title":"Lancet"},{"key":"37_CR23","volume-title":"Metadon p\u00e5 liv och d\u00f6d. En bok om narkomanv\u00e5rd och narkotikapolitik i Sverige","author":"B Johnson","year":"2005","unstructured":"Johnson B. Metadon p\u00e5 liv och d\u00f6d. En bok om narkomanv\u00e5rd och narkotikapolitik i Sverige. Lund: Studentlitteratur; 2005."},{"issue":"5","key":"37_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","volume":"164","author":"J Kakko","year":"2007","unstructured":"Kakko J, Gr\u00f6nbladh L, Svanborg KD, von Wachenfeldt J, R\u00fcck C, Rawlings B, et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 2007;164(5):797\u2013803.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"37_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/16066359.2010.545158","volume":"19","author":"M Ekendahl","year":"2011","unstructured":"Ekendahl M. The limits of legitimacy: service providers\u2019 views on maintenance treatment in Sweden. Addic Res Theory. 2011;19(5):427\u201337.","journal-title":"Addic Res Theory"},{"key":"37_CR26","volume-title":"Policyspridning som \u00f6vers\u00e4ttning. Den politiska \u00f6vers\u00e4ttningen av metadonbehandling och husl\u00e4kare i Sverige","author":"B Johnson","year":"2003","unstructured":"Johnson B. Policyspridning som \u00f6vers\u00e4ttning. Den politiska \u00f6vers\u00e4ttningen av metadonbehandling och husl\u00e4kare i Sverige. Malm\u00f6: Arbetslivsinstitutet; 2003."},{"key":"37_CR27","volume-title":"On the margins: Nordic alcohol and drug treatment 1885\u20132007","author":"B Johnson","year":"2007","unstructured":"Johnson B. After the storm: developments in maintenance treatment policy and practice in Sweden 1987\u20132006. In: Edman J, Stenius K, editors. On the margins: Nordic alcohol and drug treatment 1885\u20132007. Helsingfors: NAD; 2007."},{"key":"37_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1332\/174426409X463794","volume":"5","author":"M Ekendahl","year":"2009","unstructured":"Ekendahl M. The construction of maintenance treatment legitimacy: a discourse analysis of a policy shift. Evid Policy. 2009;5:247\u201365.","journal-title":"Evid Policy"},{"key":"37_CR29","unstructured":"SOSFS 2009:27. Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d om l\u00e4kemedelsassisterad behandling vid opiatberoende."},{"key":"37_CR30","volume-title":"Med narkotikan som f\u00f6ljeslagare: femton texter till Bengt Svensson","author":"B Johnson","year":"2013","unstructured":"Johnson B. Vetenskap och bepr\u00f6vad erfarenhet eller ett bl\u00f6tt finger i luften? In: Johnson B, Lalander P, editors. Med narkotikan som f\u00f6ljeslagare: femton texter till Bengt Svensson. Malm\u00f6: Malm\u00f6 University; 2013."},{"key":"37_CR31","unstructured":"Sj\u00f6lander J, Johnson B. Tillg\u00e4ngligheten till l\u00e4kemedelsassisterad behandling i Sverige\u2014en uppf\u00f6ljning. Malm\u00f6 h\u00f6gskola: Malm\u00f6; 2009."},{"key":"37_CR32","unstructured":"SOSFS 2004:8. Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d om l\u00e4kemedelsassisterad behandling vid opiatberoende."},{"key":"37_CR33","doi-asserted-by":"crossref","unstructured":"Johnson B, Richert T. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors. Int J Drug Policy, doi:10.1016\/j.drugpo.2014.10.003.","DOI":"10.1016\/j.drugpo.2014.10.003"},{"issue":"2","key":"37_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2478\/v10199-012-0012-0","volume":"29","author":"B Svensson","year":"2012","unstructured":"Svensson B, Andersson M. Involuntary discharge from medication-assisted treatment for people with a heroin addiction\u2014patients\u2019 experiences and interpretations. Nord Stud Alcohol Dr. 2012;29(2):173\u201393.","journal-title":"Nord Stud Alcohol Dr"},{"issue":"18","key":"37_CR35","first-page":"1225","volume":"107","author":"A Fugelstad","year":"2010","unstructured":"Fugelstad A, Johansson LA, Thiblin I. Allt fler d\u00f6r av metadon (More and more people die from methadone). Lakartidningen. 2010;107(18):1225\u20138.","journal-title":"Lakartidningen"},{"key":"37_CR36","volume-title":"Den livsl\u00e5nga avgiftningen","author":"A Reunanen","year":"2012","unstructured":"Reunanen A. Den livsl\u00e5nga avgiftningen. Stockholm: KRIS; 2012."},{"issue":"4","key":"37_CR37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/002204268601600406","volume":"16","author":"B Spunt","year":"1986","unstructured":"Spunt B, Hunt DE, Lipton DS, Goldsmith DS. Methadone diversion: a new look. J Drug Issues. 1986;16(4):569\u201383.","journal-title":"J Drug Issues"},{"key":"37_CR38","unstructured":"Antoniusson E-M. Illegal Subutexanv\u00e4ndning. Mobilisering mot narkotika: Stockholm; 2007."},{"key":"37_CR39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000149631","volume":"14","author":"A Roche","year":"2008","unstructured":"Roche A, McCabe S, Smyth BR. Illicit methadone use and abuse in young people accessing treatment for opiate dependence. Eur Addict Res. 2008;14:219\u201325.","journal-title":"Eur Addict Res"},{"key":"37_CR40","doi-asserted-by":"crossref","unstructured":"Johnson B, Richert T. Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication. J Addict Dis, doi:10.1080\/10550887.2014.975617.","DOI":"10.1080\/10550887.2014.975617"},{"key":"37_CR41","doi-asserted-by":"crossref","unstructured":"Johnson B, Richert T. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective. J Psychoactive Drugs. 46(5):427\u201335.","DOI":"10.1080\/02791072.2014.960109"},{"issue":"4","key":"37_CR42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/jcp.53.4.277","volume":"53","author":"CM Milroy","year":"2000","unstructured":"Milroy CM, Forrest ARW. Methadone deaths: a toxicological analysis. J Clin Pathol. 2000;53(4):277\u201381.","journal-title":"J Clin Pathol"},{"issue":"2","key":"37_CR43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","volume":"25","author":"B M\u00e9garbane","year":"2006","unstructured":"M\u00e9garbane B, Hreiche R, Pirnay S, Marie N, Baud FJ. Does high-dose buprenorphine cause respiratory depression? Toxicol Rev. 2006;25(2):79\u201385.","journal-title":"Toxicol Rev"},{"key":"37_CR44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0261018309105179","volume":"29","author":"K Valentine","year":"2009","unstructured":"Valentine K. Evidence, values and drug treatment policy. Critical Social Policy. 2009;29:443\u201364.","journal-title":"Critical Social Policy"},{"key":"37_CR45","volume-title":"Narkotikapolitik och narkotikadebatt","author":"B Svensson","year":"2012","unstructured":"Svensson B. Narkotikapolitik och narkotikadebatt. Lund: Studentlitteratur; 2012."},{"key":"37_CR46","unstructured":"Richert T. Overdoses, income strategies and risk handling\u2014living conditions for people who inject illegal drugs. PhD thesis. Malm\u00f6 University; 2014."},{"issue":"10","key":"37_CR47","first-page":"1244","volume":"48","author":"DE Deering","year":"2011","unstructured":"Deering DE, Sheridan J, Sellman JD, Adamson SJ, Pooley S, Robertson R, et al. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addict Behav. 2011;48(10):1244\u201357.","journal-title":"Addict Behav"},{"key":"37_CR48","volume-title":"Street Ethnography","author":"E Preble","year":"1977","unstructured":"Preble E, Miller T. Methadone, wine and welfare. In: Weppner R, editor. Street Ethnography. Beverly Hills, CA: Sage Publications; 1977."},{"issue":"11&12","key":"37_CR49","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3109\/10826088509047261","volume":"20","author":"DE Hunt","year":"1985","unstructured":"Hunt DE, Lipton DS, Goldsmith DS, Strug DL, Spunt B. \u201cIt takes your heart\u201d: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 1985;20(11&12):1751\u201371.","journal-title":"Int J Addict"},{"issue":"2","key":"37_CR50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1005574918294","volume":"24","author":"P Bourgois","year":"2000","unstructured":"Bourgois P. Disciplining addictions: the bio-politics of methadone and heroin in the United States. Cult Med Psychiatry. 2000;24(2):165\u201395.","journal-title":"Cult Med Psychiatry"},{"issue":"3","key":"37_CR51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02791072.1992.10471646","volume":"24","author":"S Murphy","year":"1992","unstructured":"Murphy S, Irwin J. \u201cLiving with the dirty secret\u201d: problems of disclosure for methadone maintenance clients. J Psychoactive Drugs. 1992;24(3):257\u201364.","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"37_CR52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","volume":"35","author":"G Gerra","year":"2011","unstructured":"Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, et al. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):483\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"37_CR53","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1360-0443.2007.01979.x","volume":"102","author":"J Bell","year":"2007","unstructured":"Bell J, Shanahan M, Mutch C, Rea F, Ryan A, Batey R, et al. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. Addiction. 2007;102(12):1899\u2013907.","journal-title":"Addiction"},{"key":"37_CR54","unstructured":"\u00d6hlin L, T\u00e4tting P, Fridell M: Substitutionsbehandling med drogfri kontraktsv\u00e5rd. S\u00e5 gick det.ss 2013:110."},{"key":"37_CR55","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.drugpo.2013.10.001","volume":"24","author":"F Petersson","year":"2013","unstructured":"Petersson F. Excusing exclusion: accounting for rule-breaking and sanctions in a Swedish methadone clinic. Int J Drug Policy. 2013;24:e99\u2013104.","journal-title":"Int J Drug Policy"},{"key":"37_CR56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","volume":"82","author":"L Gr\u00f6nbladh","year":"1990","unstructured":"Gr\u00f6nbladh L, \u00d6hlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82:223\u20137.","journal-title":"Acta Psychiatr Scand"},{"issue":"16","key":"37_CR57","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4045\/tidsskr.14.0927","volume":"134","author":"T Clausen","year":"2014","unstructured":"Clausen T, \u00c5sland R, Kristensen \u00d8. Pasienter som avbryter LAR-behandling\u2014hvordan g\u00e5r det med dem? Tidsskr Nor Laegeforen. 2014;134(16):1548\u20139.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"37_CR58","volume-title":"Exit, voice, and loyalty: responses to decline in firms, organizations, and states","author":"AO Hirchman","year":"1970","unstructured":"Hirchman AO. Exit, voice, and loyalty: responses to decline in firms, organizations, and states. Cambridge, MA: Harvard University Press; 1970."},{"issue":"9","key":"37_CR59","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1360-0443.2010.02999.x","volume":"105","author":"A Romelsj\u00f6","year":"2010","unstructured":"Romelsj\u00f6 A, Engdahl B, Stenbacka M, Fugelstad A, Davstad I, Leifman A, et al. Were the changes to Sweden\u2019s maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity? Addiction. 2010;105(9):1625\u201332.","journal-title":"Addiction"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-015-0037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-015-0037-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-015-0037-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:07:54Z","timestamp":1566346074000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.harmreductionjournal.com\/content\/12\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1186\/s12954-015-0037-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,18]]},"article-number":"12"}}